The global cardiovascular-liver-metabolic syndemic: epidemiology, trends and challenges

Nicholas W S Chew1,2, Anurag Mehta3, Rachel Goh4

  • 1Department of Cardiology, National University Heart Centre, National University Health System, Singapore, Singapore. nicholas_ws_chew@nuhs.edu.sg.

PubMed

Insights

Cardiovascular-liver-metabolic diseases, including fatty liver disease, diabetes, and obesity, form a syndemic. A new framework proposes multisystem interventions to address these interconnected public health challenges.

Area of Science:

  • Public Health
  • Epidemiology
  • Metabolic Diseases

Background:

  • Metabolic-dysfunction-associated steatotic liver disease (MASLD), type 2 diabetes mellitus (T2DM), obesity, and cardiovascular disease (CVD) are escalating global epidemics.
  • These conditions often coexist, forming a cardiovascular-liver-metabolic (CLM) syndemic with shared underlying mechanisms and socioeconomic drivers.

Purpose of the Study:

  • To establish a unified framework for understanding and addressing the CLM syndemic.
  • To present epidemiological data on the current burden and future trends of CLM diseases.
  • To discuss challenges and propose integrated solutions for CLM health promotion.

Main Methods:

  • Review of epidemiological data to illustrate disease burden and trends.
  • Development of a micro-meso-macro framework for CLM health interventions.
  • Analysis of socioeconomic influences and competing risks within the CLM construct.

Main Results:

  • The CLM syndemic presents a significant and growing public health challenge.
  • A proposed micro-meso-macro framework integrates strategies from individual risk prediction to macro-level social determinants.
  • Multisystem interventions are necessary to simultaneously address the interconnected CLM disease epidemics.

Conclusions:

  • Addressing the CLM syndemic requires a comprehensive, multi-level approach.
  • Integrating precision prevention, community-based health promotion, and systemic interventions is crucial.
  • Tackling inequities in social and commercial determinants of health is essential for effective CLM disease control.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
878
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
391
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.8K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
325
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
354